TALARIS THERAPEUTICS
Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary allogeneic cell therapy product has shown to induce tolerance in recipients of solid organ transplants from unmatched and unrelated donors, enabling living donor kidney transplant recipients to wean completely off immunosuppression one year after transplant.
TALARIS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2002-01-01
Address:
Louisville, Kentucky, United States
Country:
United States
Website Url:
http://www.talaristx.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
215 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Google Maps Content Delivery Network Organization Schema Cloudflare CDN ReCAPTCHA V2 Cloudflare Product Schema
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Viking Global Investors
Viking Global Investors investment in Series B - Talaris Therapeutics
Eventide
Eventide investment in Series B - Talaris Therapeutics
Longitude Capital
Longitude Capital investment in Series B - Talaris Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Talaris Therapeutics
Pamoja Capital
Pamoja Capital investment in Series B - Talaris Therapeutics
Invus
Invus investment in Series B - Talaris Therapeutics
Aisling Capital
Aisling Capital investment in Series B - Talaris Therapeutics
BlackRock
BlackRock investment in Series B - Talaris Therapeutics
Blackstone Life Sciences
Blackstone Life Sciences investment in Series B - Talaris Therapeutics
Logos Capital
Logos Capital investment in Series B - Talaris Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-03-04 | Talaris Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer |
Official Site Inspections
http://www.talaristx.com
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Talaris Therapeutics"
Talaris Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Talaris Therapeutics is a operator of a biotechnology company engaged in the development of innovative cellular therapies. The company's proprietary …See details»
Talaris Therapeutics Louisville - Crunchbase Company Profile
Talaris Therapeutics is a biotechnology company that focuses on the development of cell therapies. The company's primary aim is to improve the lives of kidney transplant recipients …See details»
Talaris Therapeutics - Company Profile & Staff Directory
Talaris Therapeutics, Inc. is a cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood …See details»
Talaris Therapeutics
Nov 21, 2024 Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic …See details»
Talaris Therapeutics Company Overview, Contact Details
Oct 6, 2020 [email protected]: [email protected]: 1%. See more formats. Frequently Asked Questions Where is Talaris Therapeutics 's headquarters located? Talaris Therapeutics …See details»
Working At Talaris Therapeutics: Company Overview and Culture
Talaristx.com. Organization Type. Public. Social Media. Talaris Therapeutics is a late-clinical stage biotechnology company developing transformative cell therapies with the potential to eliminate …See details»
Talaris Therapeutics Overview | SignalHire Company Profile
Talaris Therapeutics is a public company that has been in the industry for 35 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is …See details»
Talaris’s Competitors, Revenue, Number of Employees, Funding
Talaris’s Profile, Revenue and Employees. Talaris is a Massachusetts-based biotechnology company that researches and develops single-dose cell therapeutics for the treatment of auto …See details»
Talaris Therapeutics - Craft
Oct 19, 2023 Talaris Therapeutics is a cell therapy company developing an method of allogeneic hematopoietic stem cell transplantation. Its Facilitated Allo-HSCT Therapy can prevent organ …See details»
About TALARIS THERAPEUTICS, INC. | DxMultiomics
Talaristx.com. Mark. Talaris Therapeutics, Inc. is developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood …See details»
Talaris Therapeutics - VentureRadar
Website: https://talaristx.com/ Develops innovative allogeneic hematopoietic stem cell transplantation methods for solid organ transplantation, autoimmune diseases ...See details»
Talaris Therapeutics - PitchBook
Talaris Therapeutics General Information Description. Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential …See details»
Talaris Company Profile | Toronto, ON, Canada - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Talaris of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Talaris Therapeutics, Inc. Company Information - Simply Wall St
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. …See details»
Talaris Therapeutics, Inc | (502) 569-1059 | Louisville, Kentucky
The website for Talaris Therapeutics, Inc is www.talaristx.com. Q7. What are the annual sales for Talaris Therapeutics, Inc? Talaris Therapeutics, ... International Organization of Life Science …See details»
Talaris Therapeutics: Employee Directory | ZoomInfo.com
May 27, 2024 Talaris Therapeutics Contact Info: Phone number: (502) 398-9250 Website: www.talaristx.com What does Talaris Therapeutics do? Talaris Therapeutics, Inc. is a late …See details»
Talaris Therapeutics and Tourmaline Bio Announce Merger …
Jun 22, 2023 Merger to create Nasdaq-listed, late-stage clinical biotechnology company focused on developing Tourmaline’s anti-IL-6 antibody (TOUR006) in thyroid eye disease (TED) and …See details»
Talaris Therapeutics Layoffs - TheLayoff.com
Company information: Industry/Area of Activity: Biotech Company Stock Ticker: TALS Stock traded at: XNAS About Talaris Therapeutics: Talaris Therapeutics is a late-clinical stage cell …See details»
Talaris Therapeutics Inc. - Facebook
Talaris Therapeutics Inc. 86 likes. Talaris Therapeutics is a biotech company harnessing the power of immune toleranceSee details»
Talaris Therapeutics Announces Collaboration With Kentucky …
Sep 14, 2020 www.TalarisTx.com. About Kentucky Organ Donor Affiliates (KODA) ... KODA is an independent, federally designated, non-profit organ and tissue procurement organization …See details»